100 related articles for article (PubMed ID: 30060264)
1. The Enhanced Cytotoxic Effects of the p28-Apoptin Chimeric Protein As A Novel Anti-Cancer Agent on Breast Cancer Cell Lines.
Noei A; Nili-Ahmadabadi A; Soleimani M
Drug Res (Stuttg); 2019 Feb; 69(3):144-150. PubMed ID: 30060264
[TBL] [Abstract][Full Text] [Related]
2. A novel chimeric protein with enhanced cytotoxic effects on breast cancer in vitro and in vivo.
Hazrati F; Saidijam M; Ahmadyousefi Y; Nouri F; Ghadimipour H; Moradi M; Haddadi R; Soleimani M
Proteins; 2022 Apr; 90(4):936-946. PubMed ID: 34812523
[TBL] [Abstract][Full Text] [Related]
3. Production and evaluation of cytotoxic effects of DT386-BR2 fusion protein as a novel anti-cancer agent.
Shafiee F; Rabbani M; Jahanian-Najafabadi A
J Microbiol Methods; 2016 Nov; 130():100-105. PubMed ID: 27609715
[TBL] [Abstract][Full Text] [Related]
4. A Bi-Functional Targeted P28-NRC Chimeric Protein with Enhanced Cytotoxic Effects on Breast Cancer Cell Lines.
Soleimani M; Mirmohammmad Sadeghi H; Jahanian-Najafabadi A
Iran J Pharm Res; 2019; 18(2):735-744. PubMed ID: 31531057
[TBL] [Abstract][Full Text] [Related]
5. A novel tumor-activated ALA fusion protein for specific inhibition on the growth and invasion of breast cancer cells MDA-MB-231.
Liu X; Liu X; Sunchen S; Liu M; Shen C; Wu J; Zhao W; Yu B; Liu J
Drug Deliv; 2017 Nov; 24(1):1811-1817. PubMed ID: 29172777
[TBL] [Abstract][Full Text] [Related]
6. Potent in vitro antitumor activity of B-subunit of Shiga toxin conjugated to the diphtheria toxin against breast cancer.
Mohseni Z; Sedighian H; Halabian R; Amani J; Behzadi E; Imani Fooladi AA
Eur J Pharmacol; 2021 May; 899():174057. PubMed ID: 33753109
[TBL] [Abstract][Full Text] [Related]
7. Improved breast cancer cell-specific intracellular drug delivery and therapeutic efficacy by coupling decoration with cell penetrating peptide and SP90 peptide.
Fan LQ; Du GX; Li PF; Li MW; Sun Y; Zhao LM
Biomed Pharmacother; 2016 Dec; 84():1783-1791. PubMed ID: 27899251
[TBL] [Abstract][Full Text] [Related]
8. Molecular tumor targeting of gelonin by fusion with F3 peptide.
Ham SH; Min KA; Shin MC
Acta Pharmacol Sin; 2017 Jun; 38(6):897-906. PubMed ID: 28414205
[TBL] [Abstract][Full Text] [Related]
9. DFF40-iRGD, a novel chimeric protein with efficient cytotoxic and apoptotic effects against triple-negative breast cancer cells.
Amrollahi-Nia R; Akbari V; Shafiee F
Biotechnol Lett; 2021 Oct; 43(10):1967-1976. PubMed ID: 34482510
[TBL] [Abstract][Full Text] [Related]
10. Bifunctional fused polypeptide inhibits the growth and metastasis of breast cancer.
Liang AL; Qian HL; Zhang TT; Zhou N; Wang HJ; Men XT; Qi W; Zhang PP; Fu M; Liang X; Lin C; Liu YJ
Drug Des Devel Ther; 2015; 9():5671-86. PubMed ID: 26527862
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic activity of NN-32 toxin from Indian spectacled cobra venom on human breast cancer cell lines.
Attarde SS; Pandit SV
BMC Complement Altern Med; 2017 Nov; 17(1):503. PubMed ID: 29183371
[TBL] [Abstract][Full Text] [Related]
12. The flavonoid TL-2-8 induces cell death and immature mitophagy in breast cancer cells via abrogating the function of the AHA1/Hsp90 complex.
Liu HJ; Jiang XX; Guo YZ; Sun FH; Kou XH; Bao Y; Zhang ZQ; Lin ZH; Ding TB; Jiang L; Lei XS; Yang YH
Acta Pharmacol Sin; 2017 Oct; 38(10):1381-1393. PubMed ID: 28504248
[TBL] [Abstract][Full Text] [Related]
13. Antiproliferative Effects of Recombinant Apoptin on Lung and Breast Cancer Cell Lines.
Ezami Razliqi M; Olad G; Dorostkar R; Heydari S; Esmaeili Gouvarchin Ghaleh H
Arch Iran Med; 2020 Sep; 23(9):593-599. PubMed ID: 32979905
[TBL] [Abstract][Full Text] [Related]
14. Anti-proliferative and cytotoxic activities of Allium autumnale P. H. Davis (Amaryllidaceae) on human breast cancer cell lines MCF-7 and MDA-MB-231.
Isbilen O; Rizaner N; Volkan E
BMC Complement Altern Med; 2018 Jan; 18(1):30. PubMed ID: 29370794
[TBL] [Abstract][Full Text] [Related]
15. Scalable Production of Recombinant Membrane Active Peptides and Its Potential as a Complementary Adjunct to Conventional Chemotherapeutics.
Rothan HA; Ambikabothy J; Abdulrahman AY; Bahrani H; Golpich M; Amini E; A Rahman N; Teoh TC; Mohamed Z; Yusof R
PLoS One; 2015; 10(9):e0139248. PubMed ID: 26418816
[TBL] [Abstract][Full Text] [Related]
16. Secretion modification region-derived peptide blocks exosome release and mediates cell cycle arrest in breast cancer cells.
Huang MB; Gonzalez RR; Lillard J; Bond VC
Oncotarget; 2017 Feb; 8(7):11302-11315. PubMed ID: 28076321
[TBL] [Abstract][Full Text] [Related]
17. Expression and purification of toxic anti-breast cancer p28-NRC chimeric protein.
Soleimani M; Mirmohammad-Sadeghi H; Sadeghi-Aliabadi H; Jahanian-Najafabadi A
Adv Biomed Res; 2016; 5():70. PubMed ID: 27169101
[TBL] [Abstract][Full Text] [Related]
18. Cellular effect of styrene substituted biscoumarin caused cellular apoptosis and cell cycle arrest in human breast cancer cells.
Perumalsamy H; Sankarapandian K; Kandaswamy N; Balusamy SR; Periyathambi D; Raveendiran N
Int J Biochem Cell Biol; 2017 Nov; 92():104-114. PubMed ID: 28958615
[TBL] [Abstract][Full Text] [Related]
19. Growth-inhibitory effects of TGFαL3-SEB chimeric protein on colon cancer cell line.
Maleki F; Sadeghifard N; Hosseini HM; Bakhtiyari S; Goleij Z; Behzadi E; Sedighian H; Imani Fooladi AA
Biomed Pharmacother; 2019 Feb; 110():190-196. PubMed ID: 30471512
[TBL] [Abstract][Full Text] [Related]
20. Systematic comparison of the functional physico-chemical characteristics and biocidal activity of microbial derived biosurfactants on blood-derived and breast cancer cells.
Akiyode O; George D; Getti G; Boateng J
J Colloid Interface Sci; 2016 Oct; 479():221-233. PubMed ID: 27390853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
